BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17936)

  • 1. [Clinical significance of urokinase and anticoagulant activity of the urine in patients suffering from hemorrhagic fever with renal syndrome].
    Abdurashitov RF
    Urol Nefrol (Mosk); 1977; (3):10-2. PubMed ID: 17936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on quantitative determination of urokinase by radioimmunoassay and its clinical application. Part I. A new radioimmunoassay method for the quantitative determination of urokinase in urine (author's transl)].
    Wakayama Y
    Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):582-8. PubMed ID: 1243728
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary urokinase and blood fibrinolytic activity in patients with diabetes mellitus].
    Kaniak J; Kotschy M; Janukowicz-Lorenz H; Plamieniak L
    Pol Tyg Lek; 1975 Dec; 30(48):1889-91. PubMed ID: 1197079
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of urokinase in the urine using thrombelastography and the fibrin-plate test].
    Stein G; Lindner M; Schultz C; Neumann W
    Z Gesamte Inn Med; 1974 Dec; 29(24):1027-30. PubMed ID: 4458319
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of orthostatic changes on urokinase excretion.
    Wilcox GM; Hial V; Horwitz D; Pisano JJ; Keiser HR
    Thromb Haemost; 1978 Feb; 39(1):69-73. PubMed ID: 580506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Product E, urokinase and uropepsinogen in the urine of diabetic children].
    Symonides-Lawecka A; Galczak W; Olech K; Wysocki M
    Pediatr Pol; 1978 May; 53(5):593-8. PubMed ID: 683753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urina urokinase and blood fibrinolytic activity in w experimental zinc poisoning].
    Guja A
    Patol Pol; 1977; 28(2):201-8. PubMed ID: 887291
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary urokinase and blood fibrinolytic activity in patients with nephrolithiasis and other urinary tract diseases].
    Kotschy M; Lorenz T; Kaniak J; Janukowicz-Lorenz H; Lorenz J; Dabrowska B
    Pol Tyg Lek; 1975 Oct; 30(43):1773-7. PubMed ID: 52868
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasminogen activator in nephrotic syndrome.
    Andreenko GV; Podoroldskaya LV; Polyantseva LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):351-5. PubMed ID: 2465229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assay method for urinary urokinase using synthetic fluorogenic substrate (author's transl)].
    Suzuki K; Nishioka J; Hashimoto S
    Rinsho Byori; 1979 Mar; 27(3):218-22. PubMed ID: 439470
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification of high molecular weight urokinase from human urine and comparative study of two active forms of urokinase.
    Shibatani T; Kakimoto T; Chibata I
    Thromb Haemost; 1983 Apr; 49(2):91-5. PubMed ID: 6346574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and renal localisation of urokinase.
    Andrassy K; Ritz E
    Curr Probl Clin Biochem; 1979; (9):330-41. PubMed ID: 109250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diuresis on urokinase excretion rate.
    Matsuo O; Kawaguchi T; Kosugi T; Mihara H; Kimura T
    Thromb Haemost; 1979 Aug; 42(2):596-602. PubMed ID: 505366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on unexplained renal hematuria. II. Experimental studies on changes in fibrinolytic enzyme systems of dogs due to renal venous congestion and ischemia (author's transl)].
    Hayashi M
    Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):60-73. PubMed ID: 7024605
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of furosemide on plasma fibrinolytic activity and urokinase excretion.
    Chohan IS; Singh I; Vermylen J; Verstraete M
    Exp Hematol; 1977 Mar; 5(2):153-7. PubMed ID: 844519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of urokinase lysis time in patients with various renal diseases].
    Shimizu K; Kishi T; Ootaka M; Yamamoto J; Shibata M; Ban I; Sakai H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1233-41. PubMed ID: 6762457
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies on two active enzyme forms of human urinary urokinase. II. pH-and heat-stabilities of plasminogen activator activity.
    Miwa N; Obata Y; Suzuki A
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):472-5. PubMed ID: 7023710
    [No Abstract]   [Full Text] [Related]  

  • 18. [Concentration of acid-stable inhibitors--metabolites of plasma inter-alpha trypsin inhibitor--in the urine of healthy people and in patients with nephrotic syndrome].
    Ogloblina OG; Poliantseva LR; Paskhina TS
    Vopr Med Khim; 1984; 30(2):104-8. PubMed ID: 6204451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on urokinase and plasminogen activator from cultured pancreatic carcinoma.
    Wu MC; Yunis AA
    Int J Biochem; 1979; 10(12):1001-6. PubMed ID: 116877
    [No Abstract]   [Full Text] [Related]  

  • 20. [The functional activity of plasminogen activators in the blood plasma and urine of patients with lupus nephritis].
    Poliantseva LR; Tareeva IE; Bobkova IN; Podorol'skaia LV; Andreenko GV
    Ter Arkh; 1994; 66(6):39-41. PubMed ID: 7940365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.